Skip to content

Frontlight ResearchEarly access

Trial site

Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori", IRCCS - Oncologia

Meldola, ItalyNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Kidney cancer

Closed trials

Completed
A Study of the Effectiveness of Cabozantinib in Combination With Nivolumab as First-line Treatment of Advanced Renal Cell Carcinoma (aRCC) in Adults
NCT05361434· Ipsen· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori", IRCCS - Oncologia: trial site – Frontlight Research